Upharmacia March 2017
CIS REGION PHARMA
NEWS
B elarus
Pfizer plans to establish
contract manufacturing of its
medicines at the facilities of RUE Belmedpre-
paraty, the Head of Innovative Development
of the Belarus company said.
— —
— — At the meeting with the representatives
of Indian pharmaceutical companies, the
Chairman of the Council of the Republic
stated that Belarus intends to increase the
number of joint pharmaceutical projects
with India. Currently, the countries are
implementing three investment projects in
drug manufacturing.
— — In 2H2017, the sofosbuvir generic Gepasoft
(Global Napi Pharmaceuticals, Egypt) will be
launched in Belarus. The declared price of a
pack is to amount USD 800. The original drug
of Gilead is not registered in the country.
K azakhstan
Huray Pharmaceuticals
(United Arab Emirates) presented
the plan for the construction of the plant
for manufacturing of medical products
and medicines in Tassay industrial zone
(Shymkent). The cost of the project is USD 34
mio.
— —
K yrgyzstan
Kyrgyzstan is developing
the opportunity of establishing
export of herbal medicines to Armenia, the
speaker of videobridge “Kyrgyzstan-Armenia:
economic partnership and prospects” said.
— —
www.upharma-c.com
R ussia
According to DSM Group
analytical company projection,
in 2017, the overall pharmaceutical market of
Russia may grow 8-9% y-o-y. The Director of
Analytics of RNC Pharma company forecasted
10% y-o-y growth.
— —
— — According to DSM Group company, in 2016,
the retail sales on drugs amounted RUB 611bn
for 4.12bn packs. The market has grown 8.8%
y-o-y in values and 3.4% y-o-y in volumes.
— — Russian producer of pharmaceutical
substances Active Component company plans
to invest RUB 2 bn in the construction of the
new plant in Pushkinsky pharm cluster (St.
Petersburg region). 70% of the funds are
planned to attract from external sources. The
plan will start operating in 2019-2020.
— — Pharmacy chain 36,6 and online store OZON.
ru launched the joint project on remote sale
of drugs and medical devices in Russia. The
products could be booked on Internet sites of
both companies, but the payment and delivery
are carried in 36,6 pharmacies. In case if
the legislative restrictions for the distance
trade of medicines in Russia are completely
removed, the courier delivery will be carried
out by OZON.ru.
— — NacImBio (part of RosTech Corporation),
Pharmstantard and Kedrion Biopharma (Italy)
signed the contract on establishing of Kirov
Plasma company for the manufacturing of
drug from human blood plasma.
— — The range of research organizations signed
agreement on formation of pharmaceutical
cluster of Moscow region. The agreement
provides combining the competences of
participants in the development and research
of medicines.
11